Obstetrics and Gynecology

1046 questions

Question 621Question →

An expectant mother at 3131 weeks of gestation arrives at the obstetric clinic for a routine assessment. The 2727-year-old patient notes that over the past few weeks, her shoes have felt tight by the evening and she experiences mild dyspnea after walking up a single flight of stairs. She denies headaches, visual disturbances, and right upper quadrant abdominal pain. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 116/74 mm Hg116/74\text{ mm Hg}, pulse 96/min96/\text{min}, and respirations 18/min18/\text{min}. Physical examination reveals a point of maximal impulse that is displaced upward and to the left. Cardiac auscultation demonstrates an early systolic murmur (grade 2/62/6) at the left sternal border and an audible third heart sound (S3S_3). Lungs are clear to auscultation bilaterally. The lower extremities show 1+1+ bilateral pitting edema. Laboratory evaluation reveals the following:

Leukocyte count: 13,500/mm313,500/\text{mm}^3
Hemoglobin: 11.2 g/dL11.2\text{ g/dL}
Platelet count: 155,000/mm3155,000/\text{mm}^3
Serum creatinine: 0.5 mg/dL0.5\text{ mg/dL}

Urine dipstick is negative for protein. Which of the following is the most appropriate action for this patient's current presentation?

Show answer & explanation

Answer: Advise the patient that these findings are expected and maintain the current care plan

Answer

Advise the patient that these findings are expected and maintain the current care plan
The correct action is to reassure the patient and continue routine prenatal care, as her clinical presentation reflects classic physiological adaptations to pregnancy. In the third trimester, maternal blood volume increases by up to 50%, leading to an increased cardiac output that often manifests as a prominent point of maximal impulse, a benign early systolic ejection murmur, and an S3 gallop. The growing uterus displaces the diaphragm upward, causing mild dyspnea, and compresses the inferior vena cava, resulting in dependent pedal edema. Furthermore, her laboratory findings are completely normal: the hemoglobin level of 11.2 g/dL is above the third-trimester threshold for anemia (< 11.0 g/dL) due to normal hemodilution, and her leukocyte count of 13,500/mm^3 is a well-documented physiological leukocytosis of pregnancy.

Step-by-Step Solution

1
Analyze the patient's symptoms and physical exam findings in the context of late pregnancy.
The dyspnea, dependent edema, displaced point of maximal impulse, grade 2/6 systolic murmur, and S3 gallop are identified as standard physiological adaptations.
Increased plasma volume and cardiac output cause functional flow murmurs and an S3, while the expanding uterus displaces the diaphragm upward and compresses the inferior vena cava, causing mild dyspnea and pedal edema.
2
Evaluate the laboratory results against pregnancy-specific reference ranges.
Hemoglobin of 11.2 g/dL and a leukocyte count of 13,500/mm^3 are both within normal limits for a pregnant patient.
Dilutional anemia occurs because plasma volume expansion (40-50%) exceeds red blood cell mass expansion (20-30%). A physiologic leukocytosis is also expected during normal pregnancy.
3
Determine the most appropriate clinical intervention based on the assessment.
No additional diagnostic testing or medication is required.
All clinical and laboratory findings reflect a normal, healthy pregnancy progression, making routine prenatal care the only necessary action.

Key Concept

Normal physiologic adaptations of pregnancy include mild exertional dyspnea, dependent edema, a systolic flow murmur, an S3 gallop, dilutional anemia, and mild leukocytosis.
Question 622Question →

A 34-year-old G4P3 woman experiences massive postpartum hemorrhage due to uterine atony immediately following an uncomplicated vaginal delivery of a 4100-g (9 lb) neonate. Despite the administration of continuous intravenous oxytocin and vigorous bimanual uterine massage, profuse vaginal bleeding persists. Her blood pressure decreases to 76/40 mm Hg and her heart rate increases to 132/min. Assuming each successive intervention fails to arrest the hemorrhage, arrange the following management steps in the correct escalating sequence according to standard obstetric protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing refractory postpartum hemorrhage is: secondary uterotonics and tranexamic acid, followed by intrauterine balloon tamponade, then exploratory laparotomy with uterine compression sutures, then internal iliac artery ligation, and finally peripartum hysterectomy as a last resort.
The standard escalation protocol for postpartum hemorrhage prioritizes the least invasive and most uterus-sparing interventions first. When primary prophylaxis (oxytocin and massage) fails, secondary uterotonics and tranexamic acid are indicated. If bleeding persists, an intrauterine balloon tamponade is placed. If mechanical tamponade is unsuccessful, the patient must be taken for an exploratory laparotomy, where uterine compression sutures (e.g., B-Lynch) are placed. If this fails, pelvic devascularization (internal iliac ligation) is attempted. Finally, peripartum hysterectomy is performed if all other measures fail to achieve hemostasis.

Step-by-Step Solution

1
Evaluate the response to initial first-line therapy (oxytocin and bimanual massage).
Hemorrhage persists with hemodynamic instability.
Identifies the condition as refractory uterine atony, requiring immediate escalation.
2
Administer secondary pharmacologic agents and antifibrinolytics.
Medical management is maximized without invasive procedures.
Medications (methylergonovine, carboprost) and tranexamic acid are the fastest and least invasive next steps.
3
Progress to mechanical tamponade.
Direct pressure is applied to the bleeding endometrial surface.
Intrauterine balloon tamponade is the most effective non-surgical intervention and can prevent the need for laparotomy.
4
Proceed to surgical management starting with uterus-sparing techniques.
Uterine compression sutures (B-Lynch) are placed, followed by internal iliac artery ligation if bleeding continues.
Surgery is necessary when less invasive methods fail, but preserving fertility and avoiding the high morbidity of hysterectomy is prioritized.
5
Perform a peripartum hysterectomy.
Definitive surgical control of hemorrhage is achieved.
This is the absolute last resort when the patient's life is in immediate danger and all uterus-sparing methods have failed.

Key Concept

The stepwise management of refractory postpartum hemorrhage progresses from medical therapy to mechanical tamponade, followed by uterus-sparing surgery, and definitively ends with hysterectomy.
Question 623Question →

A 32-year-old pregnant woman, gravida 2, para 1, is admitted to the labor and delivery unit at 39 weeks gestation in active labor. Her pregnancy has been uncomplicated. Her pulse is 86/min and blood pressure is 118/76 mm Hg. Pelvic examination reveals the cervix is 7 cm dilated and 90% effaced, with the fetal vertex at 0 station. Artificial rupture of membranes is performed to facilitate internal fetal monitoring, yielding clear amniotic fluid. Thirty minutes later, the fetal heart rate tracing demonstrates a baseline of 145/min with moderate variability. However, there are recurrent, abrupt decreases in the fetal heart rate to 90/min that last for 30 to 45 seconds before rapidly returning to the baseline. The nadir of these decelerations occurs less than 30 seconds after their onset. The nurse immediately repositions the patient into the left lateral decubitus position and administers a bolus of intravenous normal saline, but the fetal heart rate pattern persists over the next three contractions. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Amnioinfusion

Answer

The most appropriate next step in management is to perform an amnioinfusion.
The correct answer is amnioinfusion. The fetal heart rate tracing described (recurrent, abrupt decreases with the nadir occurring in less than 30 seconds) is classic for variable decelerations. Variable decelerations are caused by umbilical cord compression. In this patient, artificial rupture of membranes likely depleted the amniotic fluid volume that normally cushions the umbilical cord, leading to the new-onset decelerations. When initial, non-invasive intrauterine resuscitative measures (such as maternal repositioning to alleviate inferior vena cava compression and administering intravenous fluid boluses) fail to resolve recurrent variable decelerations, amnioinfusion is the most appropriate next step. Amnioinfusion involves instilling normal saline or lactated Ringer's solution into the uterine cavity via an intrauterine pressure catheter. This artificially increases the amniotic fluid volume, relieves the compression on the umbilical cord, and frequently resolves the decelerations, thereby preventing the need for a cesarean delivery.

Step-by-Step Solution

1
Interpret the fetal heart rate (FHR) tracing characteristics.
The FHR shows abrupt decreases with a nadir reached in less than 30 seconds, which defines variable decelerations.
Accurate interpretation of the FHR pattern is essential to determine the underlying pathophysiology.
2
Identify the etiology of the variable decelerations.
Variable decelerations are caused by umbilical cord compression, which was likely exacerbated in this patient by the artificial rupture of membranes decreasing the protective amniotic fluid volume.
Understanding the cause directs the specific resuscitative intervention.
3
Evaluate the response to initial intrauterine resuscitative measures.
Maternal repositioning and intravenous fluid boluses were attempted but failed to resolve the decelerations.
A stepwise approach is required for FHR abnormalities; failure of first-line non-invasive measures necessitates escalation.
4
Determine the next best step for persistent variable decelerations.
Amnioinfusion is indicated to restore fluid volume within the uterine cavity, thereby relieving cord compression.
Amnioinfusion is the definitive treatment for recurrent variable decelerations unresponsive to initial maneuvers, avoiding an unnecessary cesarean delivery.

Key Concept

Recurrent variable decelerations are caused by umbilical cord compression and are managed step-wise with maternal repositioning, followed by amnioinfusion if the pattern persists.
Question 624Question →

During a visit to the urgent care clinic, a 21-year-old college student describes experiencing deep, aching lower pelvic pain that has progressively worsened over the past three days. She also reports noticing blood on her toilet tissue between her regular menstrual cycles. She has had two new sexual partners in the last six months and uses oral contraceptives inconsistently. Her vital signs show a temperature of 38.3°C (100.9°F), a heart rate of 98/min, and a blood pressure of 112/72 mm Hg. Palpation of the lower abdomen elicits tenderness without guarding. A speculum examination reveals a friable cervix with thick, yellow exudate at the os. During the bimanual exam, the patient vocalizes significant pain when the cervix is mobilized laterally, and both adnexa are tender to palpation, though no discrete masses are felt. A point-of-care pregnancy test is negative. In addition to obtaining samples for nucleic acid amplification testing, which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole

Answer

Initiate outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole
The correct response is to initiate outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole. This patient's presentation of lower pelvic pain, fever, mucopurulent cervicitis, cervical motion tenderness, and adnexal tenderness is highly diagnostic for acute pelvic inflammatory disease (PID). Because PID can cause permanent tubal scarring leading to infertility or ectopic pregnancy, empiric broad-spectrum antibiotic therapy must be started immediately upon clinical suspicion. The Centers for Disease Control and Prevention (CDC) recommends an outpatient regimen consisting of a single dose of intramuscular ceftriaxone plus a 14-day course of oral doxycycline and oral metronidazole to adequately cover N. gonorrhoeae, C. trachomatis, and anaerobic vaginal flora.

Step-by-Step Solution

1
Analyze the patient's presentation and physical examination findings.
The patient has acute lower abdominal pain, intermenstrual bleeding, fever, mucopurulent cervicitis, cervical motion tenderness, and bilateral adnexal tenderness without a palpable mass.
Identifying the constellation of symptoms and signs is necessary to establish a clinical diagnosis.
2
Determine the clinical diagnosis based on established criteria.
The combination of pelvic pain, cervical motion tenderness, adnexal tenderness, and fever in a sexually active young woman strongly supports a clinical diagnosis of acute Pelvic Inflammatory Disease (PID).
PID is a clinical diagnosis; awaiting laboratory confirmation delays necessary treatment and increases the risk of complications.
3
Determine the appropriate setting and regimen for management.
The patient does not meet criteria for hospitalization (e.g., severe illness, pregnancy, tubo-ovarian abscess). Outpatient empiric therapy with IM ceftriaxone, PO doxycycline, and PO metronidazole should be initiated immediately.
Standard outpatient PID guidelines require comprehensive coverage for N. gonorrhoeae, C. trachomatis, and anaerobes.

Key Concept

Patients with a clinical diagnosis of mild-to-moderate pelvic inflammatory disease should immediately receive empiric outpatient therapy with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole to prevent long-term reproductive complications.
Estimated Time:1m 15s
Question 625Question →

Match each specific gestational age window during a normal pregnancy to the corresponding routine prenatal screening test or intervention that is optimally performed during that timeframe.

Click a left item, then click its matching right item

Items

11 to 14 weeks of gestation
18 to 22 weeks of gestation
24 to 28 weeks of gestation
36 to 37 weeks of gestation

Matches

Show answer & explanation

Answer

The optimal screening windows are matched as follows: 11 to 14 weeks for combined first-trimester screening, 18 to 22 weeks for the fetal anatomic survey ultrasound, 24 to 28 weeks for gestational diabetes screening, and 36 to 37 weeks for Group B Streptococcus rectovaginal culture.
Each prenatal screening test is scientifically validated for a specific gestational age window. Combined first-trimester screening must be done before 14 weeks due to anatomical changes in the nuchal fold. Anatomy scans require the fetus to be large enough (18-22 weeks) for clear visualization. Gestational diabetes screening at 24-28 weeks aligns with the peak anti-insulin effects of human placental lactogen. Finally, GBS screening at 36-37 weeks ensures the culture results (valid for 5 weeks) accurately reflect colonization status during term labor.

Step-by-Step Solution

1
Evaluate the 11 to 14 weeks of gestation timeframe.
Matches with combined maternal serum screening and nuchal translucency measurement.
This specific early window is required because nuchal translucency measurements become less reliable and physically harder to standardise once the fetal crown-rump length exceeds limits usually reached by 14 weeks.
2
Evaluate the 18 to 22 weeks of gestation timeframe.
Matches with detailed fetal anatomic survey ultrasound.
By 18 to 22 weeks, fetal organogenesis is complete and structures are large enough to be clearly visualized on ultrasound, allowing for the detection of structural anomalies.
3
Evaluate the 24 to 28 weeks of gestation timeframe.
Matches with initial screening for gestational diabetes mellitus.
Human placental lactogen secretion peaks during the late second to early third trimester, causing maximal maternal insulin resistance; screening earlier may yield false negatives.
4
Evaluate the 36 to 37 weeks of gestation timeframe.
Matches with rectovaginal swab culture for Group B Streptococcus colonization.
GBS cultures are valid for approximately 5 weeks. Testing at 36 to 37 weeks ensures valid results are available when a term patient goes into labor.

Key Concept

Routine prenatal care requires specific screening modalities to be performed at precise gestational ages based on fetal development and maternal physiologic adaptations.
Question 626Question →

While waiting in the obstetric triage area, a primigravida at 3838 weeks of gestation abruptly loses consciousness and exhibits generalized tonic-clonic motor activity. Moments prior to this event, she had complained of a severe, unrelenting headache and seeing 'flashing lights'. Her last recorded blood pressure, taken ten minutes earlier, was 185/115 mmHg185/115\text{ mmHg}. During the convulsion, the continuous external fetal monitor records a sudden, prolonged drop in the fetal heart rate to 65/min65\text{/min}.

Arrange the following critical management steps in the correct chronological sequence to appropriately address this acute emergency.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Position the patient laterally and ensure airway patency, 2) Administer intravenous magnesium sulfate, 3) Administer intravenous antihypertensives, 4) Allow for in utero fetal resuscitation, and 5) Proceed with expedited delivery.
The correct sequence prioritizes maternal stabilization over immediate fetal rescue. Eclamptic seizures cause maternal hypoxia and intense uterine vasospasm, leading to a transient fetal bradycardia. Securing the maternal airway and positioning (Step 1) prevents aspiration. Administering magnesium sulfate (Step 2) arrests the seizure, halting the hypoxic insult. Controlling the severe hypertension (Step 3) prevents hemorrhagic stroke. Once the mother is stabilized, the fetal heart rate typically recovers spontaneously (Step 4), allowing for a safer, expedited delivery (Step 5).

Step-by-Step Solution

1
Address maternal airway, breathing, and circulation (ABC).
Patient is placed in the left lateral decubitus position with the airway protected.
Basic life support is the universal first step to prevent aspiration and hypoxia in any unconscious or seizing patient.
2
Arrest the seizure activity.
Intravenous magnesium sulfate is administered.
Magnesium sulfate is the superior agent for treating eclamptic seizures, directly addressing the acute neurological emergency.
3
Control severe maternal hypertension.
Intravenous labetalol or hydralazine is administered.
Preventing maternal hemorrhagic stroke by lowering the blood pressure to a safe range is critical once the active convulsion is managed.
4
Assess fetal response to maternal resuscitation.
Continuous monitoring reveals in utero resuscitation as the fetal heart rate recovers.
Severe fetal bradycardia is a physiological response to maternal hypoxia and seizure-induced uterine hypertonus; operating on an unstable mother is absolutely contraindicated.
5
Perform definitive management.
The patient proceeds to expedited delivery.
Eclampsia is an absolute indication for delivery, which cures the underlying pathophysiology, but it must only be performed on a stabilized patient.

Key Concept

In the management of eclampsia complicated by fetal bradycardia, maternal stabilization (airway protection, magnesium sulfate administration, and blood pressure control) strictly precedes fetal rescue and delivery.
Question 627Question →

Match each etiology of primary postpartum hemorrhage with its classic physical examination finding or clinical presentation.

Click a left item, then click its matching right item

Items

Uterine atony
Genital tract laceration
Retained products of conception
Uterine inversion

Matches

Show answer & explanation

Answer

Uterine atony matches with a boggy uterus; genital tract lacerations match with a firm uterus and steady bleeding; retained products match with missing placental cotyledons; and uterine inversion matches with a visible mass and absent abdominal fundus.
Primary postpartum hemorrhage is systematically evaluated using the '4 Ts'. Tone (uterine atony) presents with a soft, boggy uterus. Trauma (lacerations) presents with a firm uterus and active bleeding. Tissue (retained placenta) presents with missing cotyledons on inspection. Uterine inversion is a mechanical collapse presenting with an absent abdominal fundus and a vaginal mass.

Step-by-Step Solution

1
Evaluate the presenting symptom.
Identify that the patient is experiencing primary postpartum hemorrhage.
Establishing the overarching diagnosis focuses the differential on the '4 Ts' (Tone, Trauma, Tissue, Thrombin).
2
Differentiate based on uterine tone.
A boggy uterus points to atony (Tone), whereas a firm uterus shifts suspicion toward a laceration (Trauma).
Uterine tone is the most critical first step in determining the etiology of postpartum bleeding.
3
Assess additional anatomical and gross inspection findings.
Missing placental cotyledons indicate retained tissue (Tissue), while an absent abdominal fundus with a vaginal mass confirms uterine inversion.
Specific physical findings uniquely differentiate the remaining causes of postpartum hemorrhage.

Key Concept

The etiologies of primary postpartum hemorrhage and their distinct physical examination findings.
Question 628Question →

A 31-year-old gravida 2, para 1 at 39 weeks and 4 days gestation is evaluated on the labor and delivery unit. Her prenatal course was uncomplicated. She is currently in the second stage of labor and has been actively pushing for 45 minutes with adequate epidural analgesia. The cervix is completely dilated and 100% effaced. The fetal presenting part is the vertex in the direct occiput anterior position at +3 station. Maternal vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 118/76 mmHg, and a heart rate of 88/min. Uterine contractions are occurring every 3 minutes. Over the past 5 minutes, the continuous fetal heart rate monitor demonstrates an abrupt decrease in the baseline to 75/min with absent variability and no return to the previous baseline of 145/min. Immediate repositioning of the patient to the left lateral decubitus position and administration of an intravenous normal saline bolus do not improve the tracing. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Perform an operative vaginal delivery

Answer

Perform an operative vaginal delivery
The correct choice is to perform an operative vaginal delivery. The clinical scenario describes a Category III fetal heart rate tracing (prolonged bradycardia with absent variability) that has failed to improve with standard intrauterine resuscitation, including maternal repositioning and fluid administration. This constitutes an obstetric emergency requiring immediate delivery to prevent severe fetal hypoxia and acidemia. To determine the fastest and safest route of delivery, the maternal cervical exam and fetal station must be evaluated. This patient is fully dilated (10 cm) and the fetal head is at +3 station in an occiput anterior position. These parameters fulfill the criteria for an operative vaginal delivery (using forceps or a vacuum extractor). Performing an operative vaginal delivery at the bedside is significantly faster than preparing the patient for abdominal surgery in the operating room, making it the most appropriate and safest next step.

Step-by-Step Solution

1
Analyze the fetal heart rate tracing.
The tracing shows a prolonged deceleration (bradycardia of 75/min for >5 minutes) with absent variability, constituting a Category III tracing.
A Category III tracing indicates an abnormal fetal acid-base status and a high risk of hypoxic-ischemic encephalopathy, necessitating expedited delivery.
2
Evaluate the response to intrauterine resuscitation.
Repositioning and fluid bolus failed to resolve the bradycardia.
When initial corrective measures fail in the setting of severe fetal distress, immediate provider-assisted delivery becomes the definitive management.
3
Assess the labor progress and pelvic station to choose the delivery method.
The patient is in the second stage of labor (10 cm dilated), and the fetal head is very low in the pelvis (+3 station) in a direct occiput anterior position.
These findings meet the prerequisites for an operative (instrumental) vaginal delivery, which can be executed far more rapidly in the labor room than transferring the patient to the operating room for a cesarean delivery.

Key Concept

Management of Category III fetal heart rate tracing in the second stage of labor when criteria for operative vaginal delivery are met.
Question 629Question →

A 22-year-old nulliparous woman presents to the labor unit at 38 weeks and 5 days of gestation complaining of intense, frequent contractions. Her prenatal care has been routine and uncomplicated. Vital signs are within normal limits, with a blood pressure of 118/74 mmHg and a heart rate of 88/min. She declines epidural analgesia. On digital cervical examination, she is 6 cm dilated and 100% effaced, and the fetal vertex is at 0 station. There is no evidence of vaginal bleeding.

Electronic fetal monitoring demonstrates a baseline heart rate of 145/min with minimal variability. The tocodynamometer records 7 to 8 uterine contractions per 10-minute window. Each contraction lasts approximately 80 seconds, though the uterus is soft to palpation between contractions. Symmetrical, gradual decreases in the fetal heart rate that reach their nadir after the peak of the contraction are seen repeatedly. In response, the clinical team implements left lateral maternal positioning, administers a rapid intravenous fluid bolus, and provides supplemental oxygen. Fifteen minutes later, the high contraction frequency and the abnormal fetal heart rate pattern persist.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer subcutaneous terbutaline

Answer

The most appropriate next step is to administer subcutaneous terbutaline to treat the spontaneous uterine tachysystole.
The correct answer is administering subcutaneous terbutaline. This patient exhibits spontaneous uterine tachysystole (defined as >5 contractions in 10 minutes) causing uteroplacental insufficiency, which manifests as recurrent late decelerations and minimal variability. Unrelenting contractions prevent adequate refilling of the intervillous space, leading to fetal hypoxia. When initial intrauterine resuscitative measures (repositioning, intravenous fluids, and oxygen) fail to improve the fetal status, pharmacological reduction of uterine activity is indicated. A tocolytic agent, such as subcutaneous terbutaline (a beta-2 adrenergic agonist), rapidly relaxes the uterine smooth muscle. This restores adequate uteroplacental blood flow and often normalizes the fetal heart rate, potentially averting an emergency cesarean delivery.

Step-by-Step Solution

1
Analyze the fetal heart rate (FHR) and uterine activity data.
The FHR shows minimal variability and recurrent late decelerations. The tocodynamometer shows 7 to 8 contractions in 10 minutes, which confirms uterine tachysystole.
Identifying the contraction pattern and FHR abnormalities is essential for categorizing the tracing (Category II) and determining the underlying cause, which in this case is uteroplacental insufficiency secondary to uterine hyperstimulation.
2
Evaluate the response to initial intrauterine resuscitation measures.
Left lateral positioning, intravenous fluids, and oxygen failed to resolve the abnormal FHR pattern.
Initial conservative measures aim to optimize maternal hemodynamics and oxygenation. Failure to improve indicates an immediate need for targeted medical intervention.
3
Determine the next pharmacological or surgical intervention.
Subcutaneous terbutaline is selected as the intervention.
Because the uteroplacental insufficiency is driven by spontaneous tachysystole, administering a beta-adrenergic agonist (tocolytic) relaxes the uterine musculature, restores intervillous blood flow, and often resolves the fetal compromise without requiring immediate surgery.

Key Concept

In patients with spontaneous uterine tachysystole and a Category II fetal heart rate tracing unresponsive to initial conservative measures, administration of a tocolytic (e.g., terbutaline) is the most appropriate next step to improve uteroplacental perfusion before proceeding to operative delivery.
Question 630Question →

A 31-year-old gravida 2, para 1 woman at 35 weeks gestation is brought to the emergency department due to sudden-onset, severe, continuous abdominal pain and moderate dark vaginal bleeding. Her pregnancy is complicated by chronic hypertension, for which she takes labetalol. Her blood pressure is 165/100 mm Hg, and her pulse is 115/min. On physical examination, the uterus is hypertonic, rigid, and exquisitely tender to palpation. Fetal monitoring reveals a baseline heart rate of 165/min with minimal variability and recurrent late decelerations. The tocodynamometer demonstrates high-frequency, low-amplitude contractions. Maternal repositioning, supplemental oxygen, and an intravenous fluid bolus have been administered, but the fetal heart rate tracing remains unchanged. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Emergency cesarean delivery

Answer

Emergency cesarean delivery
The patient's clinical presentation of sudden, severe abdominal pain, a rigid and tender uterus, dark vaginal bleeding, and tachysystole in the setting of chronic hypertension is highly characteristic of placental abruption (abruptio placentae). The fetal monitoring shows a baseline of 165/min, minimal variability, and recurrent late decelerations despite appropriate intrauterine resuscitative measures (repositioning, supplemental oxygen, and intravenous fluids). This indicates severe uteroplacental insufficiency and impending fetal acidemia. In the presence of a nonreassuring fetal heart rate tracing (Category III) and active placental abruption, the most appropriate next step is an emergent surgical delivery to prevent fetal demise and control maternal hemorrhage.

Step-by-Step Solution

1
Identify the primary diagnosis based on the maternal clinical presentation.
The combination of sudden and severe abdominal pain, dark vaginal bleeding, a rigid uterus, and maternal chronic hypertension strongly indicates placental abruption (abruptio placentae).
These are the classic signs of premature separation of the placenta from the uterine wall.
2
Evaluate the fetal status based on the monitoring data.
The fetal heart rate tracing shows fetal tachycardia, minimal variability, and recurrent late decelerations despite adequate intrauterine resuscitative measures.
This indicates severe uteroplacental insufficiency and impending fetal acidemia (Category III tracing).
3
Determine the optimal management plan.
The presence of placental abruption complicated by a nonreassuring fetal heart rate tracing necessitates immediate surgical intervention.
Continued expectant management or delaying for imaging will lead to fetal demise and can rapidly worsen maternal hemorrhage and coagulopathy.

Key Concept

Management of placental abruption with fetal distress
Question 631Question →

A 27-year-old primigravida presents for her initial prenatal visit at 8 weeks gestation. Her blood type is subsequently confirmed to be O, Rh(D)-negative. She experiences an uncomplicated pregnancy and delivers a healthy, Rh(D)-positive infant at 39 weeks gestation. A routine postpartum screening test indicates the presence of a significant fetomaternal hemorrhage. Arrange the following clinical steps regarding her Rh(D) management in the standard chronological sequence required to evaluate and prevent maternal alloimmunization, from the first trimester through her postpartum care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Baseline antibody screen, Repeat antibody screen at 28 weeks, Antenatal anti-D immune globulin administration, Postpartum rosette test, and finally Postpartum Kleihauer-Betke test.
The prevention of Rh(D) alloimmunization follows a strict chronological protocol. The sequence begins with a baseline atypical antibody screen at the initial prenatal visit to rule out prior sensitization. At 28 weeks, a repeat antibody screen must be drawn to confirm the patient is still not sensitized. Immediately following this negative screen, standard antenatal prophylaxis (300 mcg of anti-D immune globulin) is given. Postpartum, after confirming the infant is Rh(D)-positive, maternal blood is screened qualitatively using the rosette test to detect significant fetomaternal hemorrhage. If the rosette test is positive, the Kleihauer-Betke test (or flow cytometry) is used to quantify the volume of fetal red blood cells in the maternal circulation. This allows the physician to calculate and administer the appropriate customized dose of postpartum anti-D immune globulin (typically 300 mcg for every 30 mL of fetal whole blood).

Step-by-Step Solution

1
Identify the patient's baseline risk at the initial prenatal visit.
Because she is Rh(D)-negative, a baseline atypical antibody screen is drawn.
This establishes whether she is already alloimmunized; if positive, prophylactic immune globulin is contraindicated and the pregnancy requires high-risk maternal-fetal medicine management.
2
Determine the necessary testing at the beginning of the third trimester (28 weeks).
A repeat atypical antibody screen is performed.
This verifies that silent sensitization has not occurred during the first two trimesters, which must be confirmed before exogenous antibodies are administered.
3
Administer standard third-trimester prophylaxis.
Routine 300 mcg of anti-D immune globulin is given at 28 weeks.
This provides passive immunity during the third trimester, when the risk of minor fetomaternal hemorrhage increases.
4
Assess fetomaternal hemorrhage risk immediately postpartum.
Because the infant is confirmed to be Rh(D)-positive, a qualitative rosette test is performed on maternal blood.
This screens for the presence of a fetomaternal hemorrhage greater than 30 mL of whole fetal blood, which would exceed the coverage of a single standard 300 mcg dose of immune globulin.
5
Quantify the hemorrhage to finalize the postpartum treatment dose.
Following the positive rosette test, a Kleihauer-Betke test is performed.
This accurately calculates the exact volume of fetal blood in the maternal circulation, allowing the physician to administer the appropriate weight-based postpartum dose of anti-D immune globulin within 72 hours of delivery.

Key Concept

Rh(D) Alloimmunization Prevention Pathway
Question 632Question →

A 24-year-old primigravid woman at 39 weeks gestation is evaluated on the labor and delivery unit. She is in spontaneous active labor following an uncomplicated prenatal course. Her temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, and pulse is 82/min. Cervical examination reveals 7 cm dilation, 100% effacement, and +1 station. Continuous electronic fetal monitoring demonstrates a baseline heart rate of 145/min with moderate variability. There are periodic, symmetric, gradual decreases in the fetal heart rate that begin exactly as the uterine contractions start, reach their nadir at the peak of the contractions, and return to baseline as the contractions end. The lowest heart rate recorded during these episodes is 125/min. What is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Continue current expectant management

Answer

Continue current expectant management
The correct response is to continue expectant management. The clinical vignette describes a classic Category I fetal heart rate (FHR) tracing with early decelerations. Early decelerations are characterized by a gradual decrease in the FHR (onset to nadir ≥30 seconds) that is perfectly symmetric with the uterine contraction; the nadir of the deceleration occurs exactly at the peak of the contraction. This pattern is a benign, physiologic reflex caused by fetal head compression as the fetus descends through the birth canal. The compression alters cerebral blood flow, stimulating the vagus nerve and temporarily slowing the heart rate. Because early decelerations are not associated with fetal hypoxia or acidemia, no intrauterine resuscitation or alteration in the delivery plan is required.

Step-by-Step Solution

1
Analyze the described fetal heart rate (FHR) tracing characteristics.
The baseline (145/min) and variability (moderate) are normal. There are gradual decelerations that perfectly mirror the uterine contractions in timing.
Accurate interpretation of the FHR tracing is required to classify it and determine if the fetus is experiencing distress.
2
Correlate the specific FHR deceleration pattern with its underlying physiologic or pathologic etiology.
Symmetric, gradual decelerations with a nadir aligning with the peak of the contraction are defined as early decelerations, which result from fetal head compression.
Differentiating between early (head compression), variable (cord compression), and late (uteroplacental insufficiency) decelerations dictates the clinical approach.
3
Determine the appropriate management based on the etiology of the decelerations.
Because early decelerations are a benign reflex mediated by increased vagal tone and do not indicate fetal hypoxia, no intervention is needed. Expectant management should be continued.
Unnecessary interventions must be avoided in reassuring, Category I fetal heart rate tracings.

Key Concept

Early decelerations are a benign, physiologic fetal heart rate pattern caused by fetal head compression during uterine contractions and require expectant management.
Question 633Question →

Identify the most likely underlying obstetric complication for each of the following acute intrapartum or postpartum presentations.

Click a left item, then click its matching right item

Items

Continuous, bright red vaginal bleeding in the presence of a firm, contracted, midline fundus following an operative vaginal delivery.
Massive postpartum hemorrhage accompanied by a soft, boggy fundus palpable well above the umbilicus following a prolonged induction of labor.
Sudden cessation of uterine contractions, acute abdominal pain, and loss of fetal station during a trial of labor after cesarean.
Severe postpartum hemorrhage, maternal shock, and a smooth, dark red mass protruding from the vagina with an abdominally nonpalpable fundus.

Matches

Show answer & explanation

Answer

The firm uterus with bleeding matches genital tract laceration; the boggy uterus matches uterine atony; the loss of fetal station matches uterine rupture; and the vaginal mass with missing abdominal fundus matches uterine inversion.
Each clinical scenario contains pathognomonic physical examination findings that directly identify the specific obstetric complication. Palpation of the fundus (firm, boggy, or absent) and fetal station progression are key differentiating factors.

Step-by-Step Solution

1
Analyze the first presentation focusing on uterine tone.
The uterus is firm and contracted.
A firm uterus rules out atony, suggesting a traumatic source like a laceration.
2
Evaluate the second presentation's physical findings.
The fundus is soft and boggy.
This physical exam finding specifically identifies a failure of the uterine muscle to clamp down on spiral arteries.
3
Assess the third presentation's intrapartum changes.
Loss of fetal station and cessation of contractions occurred.
These catastrophic changes indicate the fetus has moved outside the uterine cavity.
4
Examine the fourth presentation's anatomical landmarks.
The fundus is absent abdominally and presents as a vaginal mass.
This confirms the uterus has turned inside out.

Key Concept

Diagnosis and management of acute intrapartum and postpartum hemorrhagic emergencies
Question 634Question →

A 45-year-old woman is evaluated in the clinic for persistent vaginal symptoms. Three weeks ago, she presented with a profuse, malodorous, yellowish-green vaginal discharge and severe vulvar pruritus. At that time, speculum examination revealed punctate macular hemorrhages on the ectocervix. A saline wet mount confirmed the presence of motile, flagellated organisms with multiple polymorphonuclear leukocytes. The vaginal pH was 6.56.5. She was prescribed a 77-day course of oral metronidazole, 500500 mg twice daily. During today's visit, she reports that her symptoms briefly improved but completely returned five days ago. The patient confirms strict adherence to the prescribed medication regimen and states she has abstained from all sexual contact since before her initial visit. Her medical history is otherwise unremarkable. Repeat saline microscopy of the discharge today demonstrates the same motile organisms seen previously. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate a 7-day course of oral tinidazole

Answer

Initiate a 7-day course of oral tinidazole
The correct answer is to initiate a 7-day course of high-dose oral tinidazole. The patient has refractory trichomoniasis. She was treated with the standard initial regimen for women (7 days of oral metronidazole 500 mg twice daily). Because she strictly adhered to the regimen and completely abstained from sexual intercourse, reinfection is effectively excluded, pointing to a nitroimidazole-resistant strain. The CDC recommends treating such documented treatment failures with an escalated regimen of a 7-day course of either oral metronidazole 2 g daily or oral tinidazole 2 g daily.

Step-by-Step Solution

1
Identify the underlying organism from the initial presentation and microscopic findings.
Trichomonas vaginalis (motile, flagellated protozoa, strawberry cervix, pH > 4.5).
Establishes the baseline diagnosis required to evaluate the clinical course.
2
Evaluate the patient's response to the initial standard therapy (77 days of oral metronidazole).
Treatment failure confirmed by recurrent symptoms and a positive repeat wet mount.
Determines that the initial pharmacotherapy was unsuccessful.
3
Determine the cause of treatment failure based on the patient's history.
Patient was fully compliant and completely abstinent, ruling out reinfection.
Differentiates true antimicrobial resistance from reinfection (which would just require repeating the initial dose and treating the partner).
4
Select the appropriate second-line pharmacotherapy for metronidazole-resistant trichomoniasis.
High-dose oral tinidazole (22 g daily for 77 days) or high-dose oral metronidazole (22 g daily for 77 days).
Standard guideline-concordant care for confirmed refractory trichomoniasis to overcome baseline nitroimidazole resistance.

Key Concept

Management of treatment-resistant Trichomonas vaginalis infection requires excluding reinfection and escalating to high-dose, 7-day systemic nitroimidazole therapy.
Estimated Time:1m 30s
Question 635Question →

A 32-year-old gravida 1 para 0 woman at 39 weeks gestation is admitted to the labor and delivery unit in active labor. Her prenatal course has been uncomplicated. Cervical examination reveals 6 cm dilation, 100% effacement, and 0 fetal station. The patient requests analgesia, and a lumbar epidural is placed. Fifteen minutes later, she reports the sudden onset of nausea and lightheadedness. Her temperature is 37.1°C (98.8°F), blood pressure is 80/45 mm Hg, and heart rate is 118/min. Prior to the epidural, continuous fetal monitoring demonstrated a baseline of 140/min with moderate variability and no decelerations. Currently, the monitor shows a sudden decrease in the fetal heart rate to 85/min that has persisted for the past 4 minutes. Uterine contractions are occurring every 3 to 4 minutes. The patient is immediately repositioned to the left lateral decubitus position and an intravenous normal saline bolus is initiated, but the maternal blood pressure remains low and the fetal heart rate remains at 85/min. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous ephedrine

Answer

Administer intravenous ephedrine
Epidural anesthesia frequently causes maternal hypotension due to sympathetic nerve blockade, which leads to systemic vasodilation and decreased venous return. This sudden drop in blood pressure significantly reduces uteroplacental perfusion, often manifesting as a fetal prolonged deceleration (a decrease in the fetal heart rate lasting between 2 and 10 minutes). Initial management includes placing the patient in the left lateral decubitus position to maximize venous return by relieving aortocaval compression and administering an intravenous fluid bolus. When these initial measures fail to rapidly correct the hemodynamics, administration of a vasopressor, such as intravenous ephedrine or phenylephrine, is the definitive next step. Vasopressors restore maternal vascular tone and blood pressure, thereby reestablishing placental blood flow and resolving fetal hypoxia.

Step-by-Step Solution

1
Diagnose the maternal complication.
The patient developed profound hypotension immediately following epidural placement.
Epidural anesthesia blocks sympathetic nerve fibers, causing systemic vasodilation, venous pooling, and decreased cardiac output.
2
Identify the cause of the fetal monitoring changes.
The fetal heart rate shows a prolonged deceleration (bradycardia).
Maternal hypotension directly decreases uteroplacental perfusion, leading to acute fetal hypoxia.
3
Evaluate the response to initial interventions.
Left lateral decubitus positioning (to relieve aortocaval compression) and intravenous fluids were insufficient to correct the blood pressure.
Initial mechanical and volume-based resuscitation did not adequately reverse the sympathetic blockade.
4
Determine the definitive next best step.
Administer a vasopressor (intravenous ephedrine or phenylephrine).
Pharmacologic vasoconstriction is required to rapidly restore maternal blood pressure, thereby restoring blood flow to the placenta and resolving the fetal deceleration.

Key Concept

Management of epidural-induced maternal hypotension and resulting fetal prolonged decelerations requires sequential intrauterine resuscitation: repositioning, intravenous fluids, and vasopressors.
Question 636Question →

A nulligravid 24-year-old female is evaluated in the emergency department for a 3-day history of progressively worsening lower pelvic pain, severe nausea, and subjective fevers. She reports having a new sexual partner over the past 2 months and admits to inconsistent barrier protection. Her temperature is 38.9°C (102.0°F), blood pressure is 100/60 mm Hg, and pulse is 112/min. Physical examination demonstrates marked bilateral lower quadrant tenderness with involuntary guarding. Speculum examination reveals a purulent endocervical exudate. Bimanual examination elicits severe cervical motion tenderness and reveals a palpable, exquisitely tender 6-cm right adnexal fullness.

Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for evaluating and managing a suspected tubo-ovarian abscess is: perform a pregnancy test, obtain a pelvic ultrasound, admit for inpatient intravenous antibiotics, reassess for potential percutaneous drainage if refractory, and transition to oral antibiotics to complete the 14-day course.
The patient presents with signs of complicated pelvic inflammatory disease (PID) and a suspected tubo-ovarian abscess (TOA). In any reproductive-age woman with an adnexal mass and acute lower abdominal pain, a pregnancy test (hCG) is the essential first step to rule out an ectopic pregnancy. A pelvic ultrasound immediately follows to characterize the mass and confirm the diagnosis of a TOA. Because the patient has a TOA and systemic signs of infection (fever, tachycardia), inpatient admission for broad-spectrum intravenous antibiotics (e.g., cefoxitin and doxycycline) is indicated. Unruptured TOAs of this size (6 cm) are initially managed medically; however, if there is no improvement after 48-72 hours, image-guided percutaneous drainage is the next required step. Once the patient demonstrates clinical improvement, she can be transitioned to an oral antibiotic regimen to complete a total 14-day course.

Step-by-Step Solution

1
Rule out ectopic pregnancy
Obtain a urine or serum beta-hCG level.
An ectopic pregnancy is a life-threatening differential diagnosis for any reproductive-age female presenting with acute lower abdominal pain and an adnexal mass, making this the mandatory first step.
2
Diagnose the adnexal mass
Perform a transvaginal or pelvic ultrasound.
Ultrasound is the preferred initial imaging modality to visualize the adnexal mass, confirming the diagnosis of a tubo-ovarian abscess and differentiating it from appendicitis or ovarian torsion.
3
Initiate first-line therapy for complicated PID
Admit to the hospital for intravenous cefoxitin and doxycycline.
Patients with a TOA require inpatient monitoring and broad-spectrum intravenous antibiotics. Medical management is first-line for unruptured TOAs less than 7 cm in diameter.
4
Evaluate response to medical management
Monitor for 48-72 hours and proceed with percutaneous drainage if no clinical improvement.
While medical management is initially preferred, persistent fever or lack of symptom relief indicates failure, necessitating minimally invasive image-guided drainage.
5
Complete the treatment course
Transition to oral antibiotics to finish a 14-day course.
Once clinical stability and improvement are achieved, the patient can be safely discharged on an oral regimen (e.g., doxycycline and metronidazole) to eradicate the infection fully.

Key Concept

Evaluation and management sequence for complicated pelvic inflammatory disease (PID) and tubo-ovarian abscess (TOA).
Question 637Question →

A 27-year-old nulligravid woman is admitted to the gynecology service with worsening lower abdominal pain, chills, and purulent vaginal discharge over the past three days. Her temperature is 38.8°C (101.8°F), blood pressure is 115/75 mm Hg, and pulse is 98/min. Pelvic examination reveals significant cervical motion tenderness and a palpable, tender left adnexal mass. A transvaginal ultrasound demonstrates a 7-cm complex, multiloculated left adnexal fluid collection consistent with a tubo-ovarian abscess. There is no free fluid in the cul-de-sac. The patient is hemodynamically stable and has a soft abdomen with normal bowel sounds. Arrange the following steps in the most appropriate chronological order for the standard evidence-based management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing a hemodynamically stable patient with a tubo-ovarian abscess begins with broad-spectrum parenteral antibiotics, followed by a 48- to 72-hour clinical observation period. If medical therapy fails during this window, minimally invasive percutaneous drainage is indicated. After stabilization, the patient is transitioned to oral antibiotics to complete a 14-day total course.
The management of a tubo-ovarian abscess (TOA) requires a systematic, evidence-based approach. For a hemodynamically stable patient with an intact TOA, immediate surgical intervention is generally avoided. The initial required step is hospital admission and the administration of broad-spectrum intravenous antibiotics (e.g., ceftriaxone, doxycycline, and metronidazole) to cover polymicrobial flora including anaerobes. The patient is then monitored closely for 48 to 72 hours. If the patient exhibits persistent fever, worsening pain, or expanding abscess size after this observational period, medical failure is suspected, and minimally invasive image-guided percutaneous drainage becomes the next best step. Once the patient demonstrates sustained clinical improvement (afebrile for 24-48 hours, resolving pain and leukocytosis), whether through medical therapy alone or following successful drainage, they can be safely transitioned to a targeted oral regimen. Finally, the patient must complete a total of 14 days of antibiotics in the outpatient setting to fully eradicate the infection.

Step-by-Step Solution

1
Administer broad-spectrum intravenous antibiotics
Provides immediate parenteral antimicrobial coverage against Neisseria gonorrhoeae, Chlamydia trachomatis, and anaerobic organisms.
Tubo-ovarian abscesses are polymicrobial infections; parenteral therapy is the definitive first-line treatment for hemodynamically stable, unruptured abscesses.
2
Monitor clinical response for 48 to 72 hours
Determines if the infection is responding to conservative medical management.
A trial of antibiotics is successful in a large majority of cases, effectively avoiding unnecessary invasive procedures in stable patients.
3
Perform image-guided percutaneous drainage
Evacuates the infected fluid collection.
Drainage is specifically indicated when the patient fails to improve clinically (e.g., persistent fever, worsening pain) after an adequate trial of intravenous antibiotics.
4
Transition to oral antibiotics
Steps down therapy and prepares the patient for hospital discharge.
Step-down therapy is appropriate once the patient is afebrile for at least 24 hours and shows significant clinical improvement.
5
Complete a 14-day total antimicrobial course
Eradicates the infection and prevents chronic pelvic inflammatory disease.
Standard clinical guidelines require a full 14-day course of therapy for all complicated pelvic inflammatory disease to prevent recurrence.

Key Concept

The standard step-wise management of a hemodynamically stable tubo-ovarian abscess (TOA) requires a 48-72 hour trial of intravenous antibiotics before considering surgical or percutaneous drainage.
Question 638Question →

Match each complex puerperal complication described in the clinical vignette to its precise pathophysiologic mechanism and cornerstone of management.

Click a left item, then click its matching right item

Items

A 28-year-old on postpartum day 3 after prolonged rupture of membranes and a cesarean delivery presents with fever, tachycardia, and an exquisitely tender uterus with purulent lochia.
A 32-year-old on postpartum day 6 presents with hectic, high-spiking fevers despite 72 hours of appropriate broad-spectrum intravenous antibiotics, maintaining a remarkably benign abdominal and pelvic examination.
A 30-year-old on postpartum day 4 after a vacuum-assisted delivery and severe perineal laceration presents with systemic toxicity and excruciating perineal pain that is disproportionate to the visible edema and wooden induration.
A 26-year-old on postpartum day 14 presents with sudden-onset heavy, bright red vaginal bleeding and an enlarged, boggy uterus on examination, while remaining afebrile without uterine tenderness.
A 35-year-old on postpartum day 21 presents with profound fatigue, inability to breastfeed, and cold intolerance following a delivery complicated by uterine atony requiring massive transfusion.

Matches

Show answer & explanation

Answer

The correct matches strictly align these classic puerperal complications with their underlying pathophysiology: Postpartum endometritis pairs with polymicrobial decidual invasion, Septic pelvic thrombophlebitis with suppurative deep vein thrombosis, Necrotizing fasciitis with synergistic fascial plane infection, Secondary postpartum hemorrhage with placental bed subinvolution, and Sheehan syndrome with pituitary ischemic necrosis.
Each clinical vignette provides pathognomonic clues for a specific postpartum complication. Identifying subtle discriminators—such as uterine tenderness versus a benign exam, or pain out of proportion to swelling—allows for the accurate pairing of each presentation with its underlying pathophysiology and definitive management.

Step-by-Step Solution

1
Analyze the first vignette focusing on the timing (day 3), risk factors (cesarean, prolonged ROM), and key findings (tender uterus, purulent lochia).
Identify postpartum endometritis.
Uterine tenderness and purulent lochia are pathognomonic for decidual/myometrial infection.
2
Analyze the second vignette focusing on the lack of response to 72 hours of appropriate antibiotics and a remarkably benign physical exam.
Identify septic pelvic thrombophlebitis.
A benign exam in the setting of hectic fevers unresponsive to appropriate antimicrobial therapy strongly suggests an infected pelvic thrombus rather than an abscess or ongoing localized infection.
3
Analyze the third vignette focusing on pain that is disproportionate to physical findings and the presence of wooden induration.
Identify necrotizing fasciitis.
Systemic toxicity combined with disproportionate pain are the hallmark early signs of deep fascial microvascular thrombosis, distinguishing it from a simple perineal wound infection.
4
Analyze the fourth vignette focusing on the delayed onset (day 14) of painless, heavy bleeding without signs of infection.
Identify secondary postpartum hemorrhage due to subinvolution.
Bleeding occurring after the first 24 hours postpartum is classified as secondary; the lack of fever points to subinvolution or retained tissue rather than an infectious etiology.
5
Analyze the fifth vignette focusing on multiaxial endocrine failure (failure to lactate, cold intolerance) following a severe hemorrhage.
Identify Sheehan syndrome.
Massive hemorrhage causes hypovolemic shock, leading to infarction of the physiologically enlarged pituitary gland.

Key Concept

Differential diagnosis, pathophysiologic mechanisms, and targeted management of severe puerperal complications.
Question 639Question →

A 24-year-old woman comes to the clinic to discuss contraceptive options. She is sexually active with a new male partner and does not desire pregnancy. The patient has a history of severe, throbbing headaches that occur once a month. Before the onset of the headache, she typically sees a "flashing zigzag line" that slowly moves across her field of vision. She has no other medical conditions and takes no daily medications. Her blood pressure is 118/76 mm Hg, and body mass index is 22 kg/m². Which of the following contraceptive methods is absolutely contraindicated in this patient?

Show answer & explanation

Answer: Combined estrogen-progestin oral contraceptive pill

Answer

The combined estrogen-progestin oral contraceptive pill is absolutely contraindicated in this patient due to her history of migraine with aura.
The correct answer is the combined estrogen-progestin oral contraceptive pill. This patient's description of a 'flashing zigzag line' preceding her severe headaches is classic for a visual aura. According to the World Health Organization (WHO) Medical Eligibility Criteria, all estrogen-containing contraceptives are absolutely contraindicated (Category 4) in women of any age who have migraine with aura. The use of exogenous estrogen in these patients synergistically elevates the risk of ischemic stroke to an unacceptable level. Safe alternatives include all progestin-only methods (pills, implants, injections, IUDs) and the non-hormonal copper IUD.

Step-by-Step Solution

1
Analyze the patient's medical history for contraindications.
The patient experiences headaches preceded by visual changes ('flashing zigzag lines'), which is diagnostic for migraine with aura.
Identifying the specific type of migraine is essential because the presence of an aura significantly alters contraceptive eligibility.
2
Apply the WHO Medical Eligibility Criteria (MEC) for contraceptive use.
Estrogen-containing contraceptives are categorized as MEC Category 4 (absolutely contraindicated) for any woman with a history of migraine with aura.
The combination of exogenous estrogen and migraine with aura synergistically and unacceptably increases the risk of ischemic stroke.
3
Evaluate the contraceptive options to find the contraindicated method.
The combined estrogen-progestin oral contraceptive pill contains estrogen, whereas the other options are either progestin-only or entirely non-hormonal.
Only estrogen-containing methods must be avoided in this patient, making the combined pill the correct answer.

Key Concept

Estrogen-containing contraceptives (such as the combined oral contraceptive pill, patch, and vaginal ring) are absolutely contraindicated in women of any age who experience migraine with aura due to an elevated risk of ischemic stroke.
Question 640Question →

Seeking evaluation at a community health clinic, a 3232-year-old woman (G2P2) reports a 33-day history of continuous, dull bilateral lower abdominal pain accompanied by new-onset malodorous vaginal discharge. She states she has been in a new monogamous sexual relationship for the past 22 months. Her medical history is unremarkable, and she uses a copper intrauterine device (IUD) that was placed 33 years ago for contraception. Vital signs show a blood pressure of 118/76 mmHg118/76\text{ mmHg}, a pulse of 88/min88\text{/min}, and a temperature of 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}). Speculum examination reveals a normal-appearing cervix with visible IUD strings and thick, yellowish-green mucopurulent discharge at the cervical os. Bimanual examination elicits significant cervical motion tenderness as well as bilateral adnexal tenderness without palpable masses. A urine pregnancy test is negative. Pelvic ultrasound confirms the IUD is appropriately positioned within the endometrial cavity and demonstrates normal-appearing ovaries with no complex fluid collections or tubo-ovarian abscesses. The patient tolerates oral fluids without difficulty. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; leave the intrauterine device in place

Answer

The most appropriate next step in management is to administer intramuscular ceftriaxone, oral doxycycline, and oral metronidazole, and to leave the intrauterine device in place.
This patient presents with mild-to-moderate pelvic inflammatory disease (PID). According to current clinical guidelines, the recommended outpatient treatment for PID consists of a single dose of intramuscular ceftriaxone combined with a 14-day course of both oral doxycycline and oral metronidazole. Metronidazole is now a mandatory component of this regimen to provide essential anaerobic coverage, which has been shown to improve overall clinical outcomes and decrease the risk of reproductive sequelae. Furthermore, for patients who develop PID while using an intrauterine device (IUD), the standard of care is to leave the device in place, initiate empiric antibiotic therapy, and reassess the patient's clinical response in 48 to 72 hours. Removal is only indicated if the patient fails to improve with appropriate medical therapy.

Step-by-Step Solution

1
Evaluate the clinical presentation and physical examination findings.
The patient is diagnosed with Pelvic Inflammatory Disease (PID) based on the classic triad of cervical motion tenderness, adnexal tenderness, and purulent cervical discharge.
Recognizing the diagnostic criteria for PID is the required first step before initiating empiric therapy.
2
Determine the severity of the illness to triage the appropriate care setting (inpatient vs. outpatient).
Outpatient management is indicated.
The patient is hemodynamically stable, has a low-grade temperature rather than a high fever, is not pregnant, tolerates oral intake, and lacks evidence of a tubo-ovarian abscess on ultrasound.
3
Select the correct pharmacotherapy regimen based on updated treatment guidelines.
A regimen of intramuscular ceftriaxone, oral doxycycline, and oral metronidazole is selected.
Current CDC guidelines require the addition of metronidazole to all standard outpatient PID regimens to provide robust anaerobic coverage, which improves outcomes and reduces complication risks.
4
Determine the proper management of the patient's intrauterine device (IUD).
The IUD is left in place.
Evidence shows that outcomes for PID are similar whether the IUD is removed or left in place. Guidelines recommend initiating antibiotics with the IUD in situ and considering removal only if there is no clinical improvement after 48 to 72 hours.

Key Concept

Outpatient treatment of uncomplicated pelvic inflammatory disease requires a regimen of intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; concurrent intrauterine devices should be left in place with reassessment at 48 to 72 hours.
Estimated Time:1m 30s
PreviousPage 32 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 32 | Examkin